SAN FRANCISCO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that it has entered into a definitive securities purchase agreement (the “Purchase Agreement”) with The Sire Group Ltd. (“Sire Group”) for the sale of the Company’s newly designated Series AA Convertible Preferred Stock (the “Preferred Stock”).
Read MoreSAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into an Asset Purchase Agreement (the “Agreement”) with Fedson, Inc., a Delaware Corporation (“Fedson”), for the sale of certain ProNeura assets including Titan’s portfolio of drug addiction products, in addition to other early development programs based on the ProNeura drug delivery technology.
Read MoreSOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board") from five (5) to eleven (11) and appointed six new directors following their election at its special meeting of stockholders held on August 15, 2022 (the "Special Meeting").
Read MoreTeraWulf – an environmental, social and governance-focused bitcoin mining company – is set for a Nasdaq listing after it agreed to merge with Ikonics, an imaging-technology company whose stock trades on Nasdaq. Source - finance.yahoo.com
Read MoreNEW YORK, April 25, 2022 (GLOBE NEWSWIRE) Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.
Read MoreMINNETONKA, Minn. and LOS ANGELES, June 13, 2022 /PRNewswire/ -- Electro-Sensors, Inc. (Nasdaq: ELSE), a leader in industrial monitoring systems, and Mobile X Global, Inc., one of the world's first connectivity-as-a-service companies, announced today that they have entered into definitive agreements to merge and re-name the combined company Mobile X Global, Inc.
Read MoreNEW YORK, NY Jan. 14, 2022 (GLOBE NEWSWIRE) Activist Investing LLC Announces 5.7% Ownership Interest in Electro-Sensors, Inc.
Read MoreNEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, an experienced private investor specializing in reverse merger and other event-driven opportunities, today filed a Schedule 13D announcing his acquisition of approximately 5.1% of the common stock outstanding of Insignia Systems, Inc. (NASDAQ: ISIG) (“ISIG” or the “Company”).
Read MoreInvesting.com – Ikonics (NASDAQ:IKNX) more than doubled during Friday’s session as the company agreed to combine with bitcoin miner TeraWulf under a new holding company. Source - finance.yahoo.com
Read MoreNEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) with 25.2% of the Company’s outstanding shares, today issued the following statement:
Read MoreNEW YORK, NY July 29, 2021 (GLOBE NEWSWIRE) -- Custodian Ventures LLC (together with its affiliates, “Custodian Ventures” or “we”), today filed a Schedule 13D announcing its acquisition of approximately 5.2% of the common stock outstanding of LM Funding America, Inc. (NASDAQ: LMFA) (“LMFA” or the “Company”).
Read MoreNEW YORK, NY July 13, 2021 (GLOBE NEWSWIRE) -- Custodian Ventures LLC (together with its affiliates, “Custodian Ventures” or “we”), today filed a Schedule 13D announcing its acquisition of approximately 9.9% of the ordinary shares outstanding of Oxbridge Re Holdings Limited (NASDAQ: OXBR) (“Oxbridge Re” or the “Company”).
Read More
